Haemonetics (HAE) Raw Materials (2011)

Haemonetics (HAE) posted quarterly Raw Materials of $35.3 million for Q4 2011, up 16.35% quarter-over-quarter from $30.4 million in Q3 2011.

Haemonetics (HAE) Raw Materials (2011) Analysis & Trends

Haemonetics' Raw Materials history runs 1 years deep, the most recent figure standing at $35.3 million for Q4 2011.

In Q4 2011, Raw Materials changed N/A year-over-year to $35.3 million; the TTM figure through Oct 2011 stood at $35.3 million (changed N/A YoY), while the FY2011 annual figure was $26.4 million, changed N/A from the prior year.
Raw Materials for Q4 2011 stood at $35.3 million, up from $30.4 million in the prior quarter.
The five-year high for Raw Materials was $35.3 million in Q4 2011, with the low at $26.4 million in Q2 2011.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	199.70 Bn	194.09 Bn	7.27 Bn
2	Stryker	129.93 Bn	126.46 Bn	4.50 Bn
3	Medtronic	120.49 Bn	111.27 Bn	6.41 Bn
4	Boston Scientific	74.60 Bn	74.06 Bn	3.85 Bn
5	Edwards Lifesciences	52.68 Bn	48.42 Bn	1.35 Bn
6	Dexcom	34.78 Bn	32.84 Bn	830.00 Mn
7	GE HealthCare Technologies	33.83 Bn	31.72 Bn	2.18 Bn
8	Koninklijke Philips	26.44 Bn	23.12 Bn	4.55 Bn
9	Steris	23.18 Bn	22.69 Bn	684.20 Mn
10	Haemonetics	4.93 Bn	4.70 Bn	202.80 Mn

Download Data